Eubel Brady & Suttman Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Eubel Brady & Suttman Asset Management's LLY Position: Q1 2026 in Review
Eubel Brady & Suttman Asset Management held its Eli Lilly (LLY) position steady in Q1 2026 at 242 shares worth $223K. The position accounts for 0.03% of the portfolio, ranked #108.
Eubel Brady & Suttman Asset Management first reported a position in LLY in Q2 2014 and has held it in 10 quarters since. The position peaked at $310K in Q1 2015. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Eubel Brady & Suttman Asset Management held 242 shares of Eli Lilly worth $223K as of Q1 2026.
- Eubel Brady & Suttman Asset Management left its Eli Lilly share count unchanged in Q1 2026.
- Eli Lilly made up 0.03% of Eubel Brady & Suttman Asset Management's portfolio in Q1 2026, its #108 holding.
- Eubel Brady & Suttman Asset Management first reported a position in Eli Lilly in Q2 2014 and has held it in 10 quarters since.
- Eubel Brady & Suttman Asset Management's Eli Lilly position peaked at $310K in Q1 2015.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Eubel Brady & Suttman Asset Management's 13F filing for Q1 2026, filed 11 May 2026.